Showing results (261-270 of 339) with videos related to

Sort By:
Pageof 34
Journal of Hypertension|October 30, 1998
Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur trial. Syst-Eur Trial InvestigatorsA E Fletcher, C J Bulpitt, J Tuomilehto, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|April 5, 2008
Romanian subjects entered in the hypertension in the very elderly trial (HYVET)D Dumitraşcui, M Comşa, Viorela Enăchescu, et al.
Lancet (London, England)|July 21, 1979
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing ProjectC J Bulpitt, L J Beilin, P Clifton, et al.
British Heart Journal|January 1, 1980
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinicsL J Beilin, C J Bulpitt, E C Coles, et al.
Journal of Hypertension|May 1, 1990
Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenololA E Fletcher, C J Bulpitt, C M Hawkins, et al.
Journal of Human Hypertension|June 1, 1988
The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP)A E Fletcher, D G Beevers, C J Bulpitt, et al.
Journal of Hypertension|February 1, 1986
The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP)C J Bulpitt, D G Beevers, A Butler, et al.
Age and Ageing|April 15, 1999
Symptoms reported by elderly patients with isolated systolic hypertension: baseline data from the SYST-EUR trial. Systolic Hypertension in EuropeC J Bulpitt, A E Fletcher, L Thijs, et al.
The Journal of Heart Valve Disease|October 23, 1997
Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valvesK S Tweden, J D Cameron, A J Razzouk, et al.
Investigative Ophthalmology & Visual Science|May 1, 1994
The decreased adhesion of Y79 retinoblastoma cells to extracellular matrix proteins is due to a deficit of integrin receptorsA P Skubitz, M D Grossman, J B McCarthy, et al.
Pageof 34